Skip to main content
. 2013 Feb 7;5:29–40. doi: 10.2147/HIV.S27765

Figure 1.

Figure 1

Comparison of chemical characteristics and target of marketed (or in advanced stage of development) human immunodeficiency virus type-1 integrase inhibitors.